JELD-WEN Holding Inc
For the period ended Dec 31, 2024. Filed Feb 20, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 20, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Financial Statements F
Index to Consolidated Financial Statements
| Report of Independent Registered Public Accounting Firm (PCAOB ID No. 238) | F-2 |
|---|---|
| Consolidated Statements of Operations for the Years Ended December 31, 2024, 2023 and 2022 | F-4 |
| Consolidated Statements of Comprehensive (Loss) Income for the Years Ended December 31, 2024, 2023 and 2022 | F-5 |
| Consolidated Balance Sheets as of December 31, 2024 and 2023 | F-6 |
| Consolidated Statements of Equity for the Years Ended December 31, 2024, 2023 and 2022 | F-7 |
| Consolidated Statements of Cash Flows for the Years Ended December 31, 2024, 2023 and 2022 | F-8 |
| Notes to Consolidated Financial Statements | F-10 |
| Note 1. Description of Company and Summary of Significant Accounting Policies | F-10 |
| Note 2. Discontinued Operations | F-16 |
| Note 3. Accounts Receivable | F-17 |
| Note 4. Inventories | F-18 |
| Note 5. Property and Equipment, Net | F-18 |
| Note 6. Goodwill | F-19 |
| Note 7. Intangible Assets, Net | F-20 |
| Note 8. Leases | F-20 |
| Note 9. Accrued Payroll and Benefits | F-22 |
| Note 10. Accrued Expenses and Other Current Liabilities | F-22 |
| Note 11. Warranty Liability | F-23 |
| Note 12. Long-Term Debt | F-23 |
| Note 13. Deferred Credits and Other Liabilities | F-25 |
| Note 14. Segment Information | F-26 |
| Note 15. Income Taxes | F-30 |
| Note 16. Capital Stock | F-34 |
| Note 17. Earnings Per Share | F-34 |
| Note 18. Stock Compensation | F-35 |
| Note 19. Restructuring and Asset-Related Charges | F-37 |
| Note 20. Held for Sale | F-40 |
| Note 21. Interest Expense, Net | F-41 |
| Note 22. Other Income, Net | F-42 |
| Note 23. Derivative Financial Instruments | F-42 |
| Note 24. Fair Value of Financial Instruments | F-44 |
| Note 25. Commitments and Contingencies | F-45 |
| Note 26. Employee Retirement and Pension Benefits | F-49 |
| Note 27. Supplemental Cash Flow Information | F-54 |
To the Board of Directors and Shareholders of JELD-WEN Holding, Inc.
Opinions on the Financial Statements and Internal Control over Financial Reporting
We have audited the accompanying consolidated balance sheets of JELD-WEN Holding, Inc. and its subsidiaries (the "Company") as of December 31, 2024 and 2023, and the related consolidated statements of operations, of comprehensive (loss) income, of equity and of cash flows for each of the three years in the period ended December 31, 2024, including the related notes (collectively referred to as the "consolidated financial statements"). We also have audited the Company's internal control over financial reporting as of December 31, 2024, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO).
In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of the Company as of December 31, 2024 and 2023, and the results of its operations and its cash flows for each of the three years in the period ended December 31, 2024 in conformity with accounting principles generally accepted in the United States of America. Also in our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2024, based on criteria established in Internal Control - Integrated Framework (2013) issued by the COSO.
Basis for Opinions
The Company's management is responsible for these consolidated financial statements, for maintaining effective internal control over financial reporting, and for its assessment of the effectiveness of internal control over financial reporting, included in Management’s Report on Internal Control over Financial Reporting appearing under Item 9A. Our responsibility is to express opinions on the Company’s consolidated financial statements and on the Company's internal control over financial reporting based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud, and whether effective internal control over financial reporting was maintained in all material respects.
Our audits of the consolidated financial statements included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audits also included performing such other procedures as we considered necessary in the circumstances. We believe that our audits provide a reasonable basis for our opinions.
Definition and Limitations of Internal Control over Financial Reporting
A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.
Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.
Critical Audit Matters
The critical audit matter communicated below is a matter arising from the current period audit of the consolidated financial statements that was communicated or required to be communicated to the audit committee and that (i) relates to accounts or disclosures that are material to the consolidated financial statements and (ii) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.
Interim and Annual Goodwill Impairment Assessments – Europe and North America Reporting Units
As described in Notes 1 and 6 to the consolidated financial statements, the Company’s consolidated goodwill balance was $315.2 million as of December 31, 2024, and the goodwill associated with the Europe and North America reporting units were $134.1 million and $181.0 million, respectively. Management tests goodwill for impairment on an annual basis during the fourth quarter and between annual tests if indicators of potential impairment exist. During the third quarter of 2024, management determined that a triggering event occurred requiring an interim goodwill impairment test for the Europe reporting unit as of September 28, 2024. Based upon the results of the interim impairment assessment, management concluded the carrying value of the Europe reporting unit exceeded its fair value and recorded a goodwill impairment charge of $63.4 million. Management performed the annual impairment assessments during the fourth quarter and quantitatively determined that the fair value of the North America reporting unit exceeded its net carrying amount and no goodwill impairment existed. Management estimates the fair value of reporting units using a combination of the income and market approaches. Under the income approach, the fair value of a reporting unit is based on a discounted cash flow analysis that contains significant assumptions and estimates including revenue growth rates, expected EBITDA margins, discount rates, capital expenditures, income tax rates, and terminal growth rates.
The principal considerations for our determination that performing procedures relating to the interim goodwill impairment assessment for the Europe reporting unit and the annual goodwill impairment assessment for the North America reporting unit is a critical audit matter are (i) the significant judgment by management when developing the fair value estimates of the Europe and North America reporting units; (ii) a high degree of auditor judgment, subjectivity, and effort in performing procedures and evaluating management’s significant assumptions related to (a) revenue growth rates, expected EBITDA margins, discount rates, and terminal growth rates for the Europe and North America reporting units and (b) the capital expenditures and income tax rates for the Europe reporting unit; and (iii) the audit effort involved the use of professionals with specialized skill and knowledge.
Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. These procedures included testing the effectiveness of controls relating to management’s goodwill impairment assessments, including controls over the valuation of the Europe and North America reporting units. These procedures included, among others (i) testing management’s process for developing the fair value estimates of the Europe and North America reporting units; (ii) evaluating the appropriateness of the discounted cash flow analyses used by management; (iii) testing the completeness and accuracy of underlying data used in the discounted cash flow analyses; and (iv) evaluating the reasonableness of the significant assumptions used by management related to (a) revenue growth rates, expected EBITDA margins, discount rates, and terminal growth rates for the Europe and North America reporting units and (b) the capital expenditures and income tax rates for the Europe reporting unit. Evaluating management’s assumptions related to (a) revenue growth rates and expected EBITDA margins for the Europe and North America reporting units and (b) the capital expenditures and income tax rates for the Europe reporting unit involved evaluating whether the assumptions used by management were reasonable considering (i) the current and past performance of the Europe and North America reporting units; (ii) the consistency with external market and industry data; and (iii) whether these assumptions were consistent with evidence obtained in other areas of the audit. Professionals with specialized skill and knowledge were used to assist in evaluating (i) the appropriateness of the discounted cash flow analyses and (ii) the reasonableness of assumptions related to the discount rates and terminal growth rates.
/s/PricewaterhouseCoopers LLP
Charlotte, North Carolina
February 20, 2025
We have served as the Company’s auditor since 2000.
| Year Ended December 31, | |||
|---|---|---|---|
| (amounts in thousands, except share and per share data) | 2024 | 2023 | 2022 |
| Net revenues | $3,775,592 | $4,304,334 | $4,543,808 |
| Cost of sales | 3,086,618 | 3,471,713 | 3,757,888 |
| Gross margin | 688,974 | 832,621 | 785,920 |
| Selling, general and administrative | 652,527 | 655,280 | 654,077 |
| Goodwill impairment (Note 6) | 94,801 | — | 54,885 |
| Restructuring and asset-related charges (Note 19) | 68,092 | 35,741 | 17,622 |
| Operating (loss) income | (126,446) | 141,600 | 59,336 |
| Interest expense, net | 67,237 | 72,258 | 82,505 |
| Loss on extinguishment and refinancing of debt (Note 12) | 1,908 | 6,487 | — |
| Other income, net (Note 22) | (24,773) | (25,719) | (53,433) |
| (Loss) income from continuing operations before taxes | (170,818) | 88,574 | 30,264 |
| Income tax expense (Note 15) | 16,762 | 63,339 | 18,041 |
| (Loss) income from continuing operations, net of tax | (187,580) | 25,235 | 12,223 |
| (Loss) gain on sale of discontinued operations, net of tax (Note 2) | (1,440) | 15,699 | — |
| Income from discontinued operations, net of tax (Note 2) | — | 21,511 | 33,504 |
| Net (loss) income | $(189,020) | $62,445 | $45,727 |
| Weighted average common shares outstanding (Note 17): | |||
| Basic | 84,989,963 | 84,995,515 | 86,374,499 |
| Diluted | 84,989,963 | 85,874,035 | 87,075,176 |
| Net (loss) income per share from continuing operations | |||
| Basic | $(2.21) | $0.30 | $0.14 |
| Diluted | $(2.21) | $0.29 | $0.14 |
| Net (loss) income per share from discontinued operations | |||
| Basic | $(0.02) | $0.44 | $0.39 |
| Diluted | $(0.02) | $0.43 | $0.38 |
| Net (loss) income per share | |||
| Basic | $(2.22) | $0.73 | $0.53 |
| Diluted | $(2.22) | $0.73 | $0.53 |
Net income per share may not sum due to rounding.
CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME
| Year Ended December 31, | |||
|---|---|---|---|
| (amounts in thousands) | 2024 | 2023 | 2022 |
| Net (loss) income | $(189,020) | $62,445 | $45,727 |
| Other comprehensive (loss) income, net of tax: | |||
| Foreign currency translation adjustments, net of tax (benefit) expense of $(34), $2,301 and $1,502, respectively. | (37,336) | 45,859 | (71,811) |
| Foreign currency hedge adjustments, net of tax expense of $23, $0 and $0, respectively. | 314 | — | — |
| Interest rate hedge adjustments, net of tax (benefit) expense of $(35), $(4,076) and $3,268, respectively. | (103) | (12,159) | 9,668 |
| Defined benefit pension plans, net of tax expense of $2,462, $3,287 and $4,104, respectively. | 2,940 | 13,624 | 13,255 |
| Total other comprehensive (loss) income, net of tax | (34,185) | 47,324 | (48,888) |
| Comprehensive (loss) income | $(223,205) | $109,769 | $(3,161) |
| (amounts in thousands, except share and per share data) | December 31, 2024 | December 31, 2023 |
|---|---|---|
| ASSETS | ||
| Current assets | ||
| Cash and cash equivalents | $150,337 | $288,312 |
| Restricted cash | 710 | 835 |
| Accounts receivable, net (Note 3) | 388,415 | 516,674 |
| Inventories (Note 4) | 460,107 | 481,451 |
| Other current assets | 73,413 | 71,507 |
| Assets held for sale (Note 20) | 126,912 | 135,563 |
| Total current assets | 1,199,894 | 1,494,342 |
| Property and equipment, net (Note 5) | 681,439 | 644,242 |
| Deferred tax assets (Note 15) | 143,284 | 150,453 |
| Goodwill (Note 6) | 315,167 | 390,170 |
| Intangible assets, net (Note 7) | 101,987 | 123,910 |
| Operating lease assets, net (Note 8) | 126,256 | 146,931 |
| Other assets | 52,142 | 30,077 |
| Total assets | $2,620,169 | $2,980,125 |
| LIABILITIES AND EQUITY | ||
| Current liabilities | ||
| Accounts payable | $264,947 | $269,322 |
| Accrued payroll and benefits (Note 9) | 89,600 | 132,550 |
| Accrued expenses and other current liabilities (Note 10) | 224,209 | 233,796 |
| Current maturities of long-term debt (Note 12) | 30,927 | 36,177 |
| Liabilities held for sale (Note 20) | 15,308 | 7,064 |
| Total current liabilities | 624,991 | 678,909 |
| Long-term debt (Note 12) | 1,152,449 | 1,190,075 |
| Unfunded pension liability (Note 26) | 21,615 | 26,502 |
| Operating lease liability (Note 8) | 105,499 | 121,993 |
| Deferred credits and other liabilities (Note 13) | 89,854 | 104,831 |
| Deferred tax liabilities (Note 15) | 5,699 | 7,170 |
| Total liabilities | 2,000,107 | 2,129,480 |
| Commitments and contingencies (Note 25) | ||
| Shareholders’ equity | ||
| Preferred Stock, par value $0.01 per share, 90,000,000 shares authorized; no shares issued and outstanding | — | — |
| Common Stock: 900,000,000 shares authorized, par value $0.01 per share, 84,653,408 and 85,309,220 shares issued and outstanding, respectively | 846 | 853 |
| Additional paid-in capital | 769,064 | 752,171 |
| (Accumulated deficit) retained earnings | (20,353) | 192,931 |
| Accumulated other comprehensive loss | (129,495) | (95,310) |
| Total shareholders’ equity | 620,062 | 850,645 |
| Total liabilities and shareholders’ equity | $2,620,169 | $2,980,125 |
CONSOLIDATED STATEMENTS OF EQUITY
| December 31, 2024 · December 31, 2023 · December 31, 2022 | ||||||||
|---|---|---|---|---|---|---|---|---|
| (amounts in thousands, except share and per share amounts) · Shares · Amount · Shares · Amount · Shares · Amount | ||||||||
| Preferred stock, $0.01 par value per share | — | $— | — | $— | — | $— | ||
| Common stock, $0.01 par value per share | ||||||||
| Balance at beginning of period | 85,309,220 | $853 | 84,347,712 | $843 | 90,193,550 | $902 | ||
| Shares issued for exercise/vesting of share-based compensation awards | 1,030,848 | 10 | 1,069,969 | 11 | 1,128,181 | 11 | ||
| Shares repurchased | (1,600,000) | (16) | — | — | (6,848,356) | (69) | ||
| Shares surrendered for tax obligations for employee share-based transactions | (86,660) | (1) | (108,461) | (1) | (125,663) | (1) | ||
| Balance at period end | 84,653,408 | $846 | 85,309,220 | $853 | 84,347,712 | $843 | ||
| Additional paid-in capital | ||||||||
| Balance at beginning of period | $752,844 | $735,526 | $720,124 | |||||
| Shares issued for exercise/vesting of share-based compensation awards | 2,868 | 552 | 1,998 | |||||
| Shares surrendered for tax obligations for employee share-based transactions | (1,440) | (1,637) | (2,764) | |||||
| Amortization of share-based compensation | 15,465 | 18,403 | 16,168 | |||||
| Balance at period end | 769,737 | 752,844 | 735,526 | |||||
| Employee stock notes | ||||||||
| Balance at beginning of period | (673) | (673) | (673) | |||||
| Net issuances, payments and accrued interest on notes | — | — | — | |||||
| Balance at period end | (673) | (673) | (673) | |||||
| Balance at period end | $769,064 | $752,171 | $734,853 | |||||
| (Accumulated deficit) retained earnings | ||||||||
| Balance at beginning of period | $192,931 | $130,486 | $215,611 | |||||
| Shares repurchased | (24,264) | — | (130,852) | |||||
| Net (loss) income | (189,020) | 62,445 | 45,727 | |||||
| Balance at period end | $(20,353) | $192,931 | $130,486 | |||||
| Accumulated other comprehensive loss | ||||||||
| Balance at beginning of period | $(95,310) | $(142,634) | $(93,746) | |||||
| Foreign currency adjustments | (37,336) | 45,859 | (71,811) | |||||
| Unrealized gain on foreign currency hedges | 314 | — | — | |||||
| Unrealized (loss) gain on interest rate hedges | (103) | (12,159) | 9,668 | |||||
| Net actuarial pension gain | 2,940 | 13,624 | 13,255 | |||||
| Balance at period end | $(129,495) | $(95,310) | $(142,634) | |||||
| Total shareholders’ equity at period end | $620,062 | $850,645 | $723,548 | |||||
The accompanying notes are an integral part of these Consolidated Financial Statements
| Year Ended December 31, | |||
|---|---|---|---|
| (amounts in thousands) | 2024 | 2023 | 2022 |
| OPERATING ACTIVITIES | |||
| Net (loss) income | $(189,020) | $62,445 | $45,727 |
| Adjustments to reconcile net income to cash provided by operating activities: | |||
| Depreciation and amortization | 125,786 | 140,192 | 131,754 |
| Deferred income taxes | (16,984) | 31,735 | (4,394) |
| Net gain on sale of business, property and equipment | (13,752) | (10,472) | (7,969) |
| Goodwill impairment | 94,801 | — | 54,885 |
| Adjustment to carrying value of assets | 22,715 | 7,862 | 2,375 |
| Amortization of deferred financing costs | 2,411 | 2,614 | 3,150 |
| Loss on extinguishment and refinancing of debt | 1,246 | 6,487 | — |
| Loss on foreign currency translation adjustment related to the substantial liquidation of a foreign subsidiary | 4,809 | — | — |
| Gain on sale of discontinued operations, net of tax | — | (23,982) | — |
| Share-based compensation expense | 15,465 | 18,403 | 16,168 |
| Amortization of U.S. pension expense | — | 480 | 1,798 |
| Recovery of cost from receipts on impaired notes | (1,389) | (3,514) | (13,953) |
| Other items, net | (5,295) | (7,439) | 24,597 |
| Net change in operating assets and liabilities: | |||
| Accounts receivable | 102,275 | 10,862 | (79,692) |
| Inventories | 9,423 | 119,560 | (73,575) |
| Other assets | (1,551) | 11,595 | (4,875) |
| Accounts payable and accrued expenses | (32,483) | (21,548) | (58,615) |
| Change in short-term and long-term tax liabilities | (12,243) | (92) | (7,044) |
| Net cash provided by operating activities | 106,214 | 345,188 | 30,337 |
| INVESTING ACTIVITIES | |||
| Purchases of property and equipment | (161,906) | (98,332) | (83,217) |
| Proceeds from sale of business, property and equipment | 20,671 | 16,751 | 11,871 |
| Purchase of intangible assets | (11,811) | (12,550) | (9,003) |
| Proceeds (payments) related to the sale of JW Australia(1) | — | 365,555 | — |
| Recovery of cost from receipts on impaired notes | 1,389 | 3,514 | 13,953 |
| Cash received for notes receivable | 46 | 261 | 94 |
| Cash received from insurance proceeds | 1,655 | 5,115 | — |
| Purchase of securities for deferred compensation plan | (3,381) | (1,140) | (728) |
| Net cash (used in) provided by investing activities | (153,337) | 279,174 | (67,030) |
| FINANCING ACTIVITIES | |||
| Change in long-term debt and payments of debt extinguishment costs | (55,178) | (561,338) | 12,729 |
| Common stock issued for exercise of options | 2,878 | 563 | 2,009 |
| Common stock repurchased | (24,280) | — | (131,987) |
| Payments to tax authorities for employee share-based compensation | (1,441) | (1,638) | (2,765) |
| Payments related to the sale of JW Australia | (2,612) | (744) | — |
| Net cash used in financing activities | (80,633) | (563,157) | (120,014) |
| Effect of foreign currency exchange rates on cash | (10,344) | 7,074 | (19,315) |
| Net (decrease) increase in cash and cash equivalents | (138,100) | 68,279 | (176,022) |
| Cash, cash equivalents and restricted cash, beginning | 289,147 | 220,868 | 396,890 |
| Cash, cash equivalents and restricted cash, ending | $151,047 | $289,147 | $220,868 |
| Balances included in the Consolidated Balance Sheets: | |||
| Cash, cash equivalents, and restricted cash | $151,047 | $289,147 | $165,938 |
|---|---|---|---|
| Cash and cash equivalents included in current assets of discontinued operations | — | — | 54,930 |
| Cash and cash equivalents at end of period | $151,047 | $289,147 | $220,868 |
| Refer to Note 27 - Supplemental Cash Flow for more information. | |||
| Cash flows from discontinued operations through the divestiture date of July 2, 2023, are included in the above amounts and explained in Note 1 — Description of Company and Summary of Significant Accounting Policies and Note 2 — Discontinued Operations. | |||
| (1) Includes proceeds from the sale of JW Australia, net of the $73.9 million of cash divested. | |||
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Note 1. Description of Company and Summary of Significant Accounting Policies
Nature of Business – JELD-WEN Holding, Inc., along with its subsidiaries, is a vertically integrated global manufacturer and distributor of windows, doors, and other building products that derives substantially all its revenues from the sale of its door and window products. Unless otherwise specified or the context otherwise requires, all references in these notes to “JELD-WEN,” “we,” “us,” “our,” or the “Company” are to JELD-WEN Holding, Inc. and its subsidiaries.
We have facilities primarily located in the U.S., Canada, and Europe. Our products are marketed primarily under the JELD-WEN brand name in the U.S. and Canada and under JELD-WEN and a variety of acquired brand names in Europe.
Our revenues are affected by the level of new housing starts, residential and non-residential building construction, and repair and remodeling activity in each of our markets. Our sales typically follow seasonal new construction and repair and remodeling industry patterns. The peak season for home construction and remodeling in many of our markets generally corresponds with the second and third calendar quarters, and therefore, sales volume is typically higher during those quarters. Our first and fourth quarter sales volumes are generally lower due to reduced repair and remodeling activity and reduced activity in the building and construction industry as a result of colder and more inclement weather in certain areas of our geographic end markets.
Basis of Presentation – The accompanying consolidated financial statements have been prepared in accordance with GAAP and pursuant to the rules and regulations of the SEC. All intercompany balances and transactions have been eliminated in consolidation.
On April 17, 2023, we entered into a Share Sale Agreement with Aristotle Holding III Pty Limited, a subsidiary of Platinum Equity Advisors, LLC, to sell JW Australia. On July 2, 2023, we completed the sale. The net assets and operations of the disposal group met the criteria to be classified as “discontinued operations” and are reported as such in all periods presented unless otherwise noted. The consolidated statements of cash flows include cash flows from discontinued operations through the divestiture date of July 2, 2023. Refer to Note 2 - Discontinued Operations for more information.
All U.S. dollar and other currency amounts, except per share amounts, are presented in thousands unless otherwise noted.
Share Repurchases – On July 28, 2022, the Board of Directors reduced our previous repurchase authorization of $400.0 million to a total aggregate value of $200.0 million with no expiration date. As of December 31, 2024, $175.7 million was remaining under the repurchase program.
During the years ended December 31, 2024 and 2022, we paid $24.3 million and $132.0 million to repurchase 1,600,000 and 6,848,356 shares of our Common Stock, respectively. We didnot repurchase shares of our Common Stock during the year ended December 31, 2023. Refer to Note 16 -Capital Stock for more information.
Fiscal Year – We operate on a fiscal calendar year, and each interim quarter is comprised of two 4-week periods and one 5-week period, with each week ending on a Saturday. Our fiscal year always begins on January 1 and ends on December 31. As a result, our first and fourth quarters may have more, or fewer days included than a traditional 91-day fiscal quarter.
Use of Estimates – The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates, assumptions, and allocations that affect amounts reported in the consolidated financial statements and related notes. Significant items that are subject to such estimates and assumptions include, but are not limited to, long-lived assets including goodwill and other intangible assets, employee benefit obligations, income tax uncertainties, contingent assets and liabilities, provisions for bad debt, inventory, warranty liabilities, legal claims, valuation of derivatives, environmental remediation, and claims relating to self-insurance. Actual results could differ due to the uncertainty inherent in the nature of these estimates.
CARES Act – In March 2020, the United States government enacted the CARES Act to provide certain relief as a result of the COVID-19 pandemic. The CARES Act provided for tax relief, along with other stimulus measures, including a provision that allowed employers to defer the remittance of the employer portion of social security tax relating to 2020. The Company deferred $20.9 million of the employer portion of social security tax in 2020, all of which was paid in the year ended December 31, 2022. The CARES Act also included a provision for an ERC designed to encourage businesses to retain employees during the COVID-19 pandemic. During the years ended December 31, 2024 and 2022 no ERC was recorded. During the year ended December 31, 2023, we recorded an ERC from the U.S. government of $6.1 million in other income, net in the accompanying consolidated statements of operations. The balance is included in other current assets in the accompanying consolidated balance sheets as of December 31, 2024 and 2023.
Segment Reporting – Our reportable segments are organized and managed principally by geographic region: North America and Europe. We report all other business activities in Corporate and unallocated costs. We consider the following factors in determining the reportable segments: the nature of business activities, the management structure accountable directly to the CODM, the discrete financial information regularly provided to the CODM, and information presented to the Board of Directors and investors. The CODM is the CEO. No operating segments have been aggregated for our presentation of reportable segments.
Cash and Cash Equivalents – We consider all highly-liquid investments purchased with an original or remaining maturity at the date of purchase of ninety days or less to be cash equivalents. Our cash management system is designed to maintain zero bank balances at certain banks. Checks written and not presented to these banks for payment are reflected as book overdrafts and are a component of accounts payable.
Restricted Cash – Restricted cash consists primarily of cash required to meet certain bank guarantees.
Accounts Receivable – Accounts receivable are recorded at their net realizable value. Our customers are primarily retailers, distributors, and contractors. Two customers, The Home Depot and Lowe’s Companies, each accounted for more than 10% of the consolidated accounts receivable, net balance as of December 31, 2024 and 2023. We maintain allowances for credit losses resulting from the inability of our customers to make required payments. We estimate the allowance for credit losses based on quantitative and qualitative factors associated with the credit risk of our accounts receivable, including historical credit collections within each region where we have operations. If the financial condition of a customer deteriorates or other circumstances occur that result in an impairment of a customer’s ability to make payments, we record additional allowances as needed. We write off uncollectible trade accounts receivable against the allowance for credit losses when collection efforts have been exhausted and/or any legal action taken by us has concluded.
Inventories – Inventories in the accompanying consolidated balance sheets are valued at the lower of cost or net realizable value and are determined by the FIFO or average cost methods. We record provisions to write down obsolete and excess inventory to its estimated net realizable value. The process for evaluating obsolete and excess inventory requires us to evaluate historical inventory usage and expected future production needs. Accelerating the disposal process or incorrect estimates may cause actual results to differ from the estimates at the time such inventory is disposed or sold. We classify certain inventories that are available for sale directly to external customers or used in the manufacturing of a finished good within raw materials.
Notes Receivable – Notes receivable are recorded at their net realizable value. The balance consists primarily of installment notes and affiliate notes. The allowance for credit losses is based upon credit risks, historical loss trends, and specific reviews of delinquent notes. We write off uncollectible note receivables against the allowance for credit losses when collection efforts have been exhausted and/or any legal action taken by us has been concluded. Current maturities and interest, net of short-term allowance are reported as other current assets.
Customer Displays – Customer displays include all costs to manufacture, ship, and install the displays of our products in retail store locations. Capitalized display costs are included in other assets and are amortized over the life of the product lines, typically 1 to 3 years. For the years ended December 31, 2024, 2023 and 2022, amortization associated with customer displays were $5.8 million, $3.9 million and $1.4 million, respectively, and are included in SG&A expense in the accompanying consolidated statements of operations.
Cloud Computing Arrangements –We capitalize qualified cloud computing implementation costs associated with the application development stage and subsequently amortize these costs over the term of the hosting agreement and stated renewal period, if it is reasonably certain we will renew, typically 3 to 5 years. Capitalized costs are included in other assets on the consolidated balance sheet and amortization is included in SG&A expense in the accompanying consolidated statement of operations.
Property and Equipment – Property and equipment are recorded at cost. The cost of major additions and betterments are capitalized and depreciated using the straight-line method over their estimated useful lives. Replacements, maintenance, and repairs that do not improve or extend the useful lives of the related assets or adapt the property to a new or different use are expensed as incurred. Interest over the construction period is capitalized as a component of cost of constructed assets. Upon sale or retirement of property or equipment, cost and related accumulated depreciation are removed from the accounts and any gain or loss is charged to income and included in SG&A expense in the accompanying statements of operations.
Leasehold improvements are amortized over the shorter of the useful life of the improvement, the lease term, or the life of the building. Depreciation is generally provided over the following estimated useful service lives:
| Land improvements | 10 - 20 years |
|---|---|
| Buildings and improvements | 10 - 45 years |
| Machinery and equipment | 3 - 20 years |
Intangible Assets – Definite lived intangible assets are amortized based on the pattern of economic benefit over the following estimated useful lives:
| Trademarks and trade names | 10 - 40 years |
|---|---|
| Software | 3 - 10 years |
| Patents, licenses and rights | 5 - 25 years |
| Customer relationships | 5 - 20 years |
The lives of definite lived intangible assets are reviewed and reduced if necessary, whenever changes in their planned use occur. Legal and registration costs related to internally developed patents and trademarks are capitalized and amortized over the lesser of their expected useful life or the legal patent life. The carrying value of intangible assets is reviewed by management to assess the recoverability of the assets when facts and circumstances indicate that the carrying value may not be recoverable. The recoverability test requires us to first compare undiscounted cash flows expected to be generated by that definite lived intangible asset or asset group to its carrying amount. If the carrying amounts of the definite lived intangible assets are not recoverable on an undiscounted cash flow basis, an impairment charge is recognized to the extent that the carrying amount exceeds its fair value. Fair value is determined through various valuation techniques.
We capitalize certain qualified internal use software costs during the application development stage and subsequently amortize these costs over the estimated useful life of the asset. Costs incurred during the preliminary project stage and post-implementation operation stage are expensed as incurred.
Long-Lived Assets – Long-lived assets, other than goodwill, are reviewed for impairment whenever events or changes in circumstances indicate the carrying amount of such assets or asset groups may not be recoverable. If a triggering event is identified, we perform an impairment test by reviewing the expected undiscounted cash flows generated from the anticipated use and eventual disposition of the asset group compared to the carrying value of the asset group. If the expected undiscounted cash flows are less than the carrying value of the asset group, then an impairment charge is required to reduce the carrying value of the asset group to fair value. Long-lived assets currently available for sale and expected to be sold within one year are classified as assets held for sale.
Leases – We lease certain warehouses, distribution centers, office spaces, land, vehicles, and equipment. We determine if an arrangement is a lease at inception. A contract contains a lease if the contract conveys the right to control the use of identified property, plant, or equipment (an identified asset) for a period of time in exchange for consideration. Amounts associated with operating leases are included in ROU assets, net, accrued expense and other current liabilities and operating lease liability in our consolidated balance sheet. Amounts associated with finance leases are included in property and equipment, net, current maturities of long-term debt, and long-term debt in our consolidated balance sheet.
ROU assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. ROU assets and liabilities are recognized at the lease commencement date based on the estimated present value of lease payments over the lease term.
If the lease does not provide an implicit rate, we use our incremental borrowing rate based on the information available at the lease commencement date in determining the present value of lease payments. The incremental borrowing rate for operating leases that commenced in the period is determined by using the prior quarter end’s incremental borrowing rates.
We have elected not to recognize an ROU asset and lease liability for leases with an initial term of twelve months or less as well as any lease covering immaterial assets. We recognize lease expense for these leases on a straight-line basis over the lease term. Variable lease payments that are dependent on usage, output, or may vary for other reasons, are excluded from lease payments in the measurement of the ROU asset and lease liability and accordingly are recognized as lease expense in the period the obligation for those payments is incurred. We combine lease and non-lease components for all agreements, except for building leases.
Certain leases include renewal and/or termination options, with renewal terms that can extend the lease term from 1 to 20 years or more, and the exercise of lease renewal options under these leases is at our sole discretion. These options are included in the lease term used to determine ROU assets and corresponding liabilities when we are reasonably certain we will exercise the option. The depreciable life of assets and leasehold improvements are limited by the expected lease term. Our lease agreements do not contain any material residual value guarantees or material restrictive covenants.
Goodwill –Goodwill is tested for impairment on an annual basis during the fourth quarter and between annual tests if indicators of potential impairment exist. Current accounting guidance provides an entity with the option to perform a qualitative assessment to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If we do not perform a qualitative assessment, or if we determine that it is more likely than not that the fair value of the reporting unit is less than its carrying amount, we perform a quantitative goodwill impairment test. Prior to 2023, the estimated fair values of reporting units were derived using only an income approach (implied fair value measured on a non-recurring basis using Level 3 inputs). Beginning in 2023, the estimated fair values of our reporting units were derived using a combination of income and market approaches, both of which yielded substantially equivalent indications of fair value. Absent an indication of fair value from a potential buyer or similar specific transactions, we believe that the use of these methods provides a reasonable estimate of a reporting unit’s fair value. Fair value computed by these models is arrived at using several factors and inputs. There are inherent uncertainties, however, related to fair value models, the inputs, factors and our judgment in applying them to this analysis. Nonetheless, we believe that the combination of these methods provides a reasonable approach to estimate the fair values of our reporting units.
Under the income approach, the fair value of a reporting unit is based on a discounted cash flow analysis of management's short-term and long-term forecast of operating performance. This analysis contains significant assumptions and estimates including revenue growth rates, expected EBITDA margins, discount rates, capital expenditures, income tax rates, and terminal growth rates. Under the market approach, we utilized a guideline company method in which the fair value of the reporting unit is based on weighting the financial multiples of comparable companies and applying a control premium. Changes in assumptions or estimates used in our goodwill impairment testing could materially affect the determination of the fair value of a reporting unit, and therefore, could eliminate the excess of fair value over carrying amount of a reporting unit and, in some cases, could result in impairment. Such changes in assumptions could be caused by items such as prolonged deterioration in economic conditions, a further decline in projected future cash flows, loss of one or more significant customers, failure to control cost increases above what can be recouped in sale price increase, or increases in the discount rates. These types of changes would negatively affect our profits, revenues, and growth over the long term and such a decline could significantly affect the fair value assessment of our reporting units and cause our goodwill to become impaired.
We identifiedtwo reporting units: North America and Europe. In determining our reporting units, we considered (i) whether an operating segment or a component of an operating segment was a business, (ii) whether discrete financial information was available, and (iii) whether the financial information is regularly reviewed by management of the operating segment.
Deferred Revenue – We record deferred revenue when we collect pre-payments from customers for performance obligations we expect to fulfill through future performance of a service or delivery of a product. We classify our deferred revenue based on our estimate as to when we expect to satisfy the related performance obligations. Deferred revenues are included in accrued expenses and other current liabilities in the accompanying consolidated balance sheets.
Warranty Accrual – Warranty terms range primarily fromone year to lifetime on certain window and door components. Warranties are normally limited to replacement or service of defective components for the original customer. Some warranties are transferable to subsequent owners and are generally limited toten years from the date of manufacture or require pro-rata payments from the customer. A provision for estimated warranty costs is recorded at the time of sale based on historical experience and we periodically adjust these provisions to reflect actual experience.
Restructuring – Costs to exit or restructure certain activities of our internal operations are accounted for as one-time termination and exit costs as required by the provisions of FASB ASC 420, Exit or Disposal Cost Obligations, and are accounted for separately from any business combination. A liability for costs associated with an exit or disposal activity is recognized and measured at its fair value in our consolidated statements of operations in the period in which the liability is incurred. When estimating the fair value of restructuring activities, assumptions are applied, which can differ materially from actual results. This may require us to revise our initial estimates, which may materially affect our results of operations and financial position in the period the revision is made.
Derivative Financial Instruments – Derivative financial instruments are used to manage interest rate risk associated with our borrowings, exposures to certain commodities associated with our material costs and foreign currency exposures related to transactions denominated in currencies other than the U.S. dollar, or in the case of our non-U.S. companies, transactions denominated in a currency other than their functional currency. All derivatives are recorded as assets or liabilities in the consolidated balance sheets at their respective fair values. As of December 31, 2024, 2023 and 2022, we had netting provisions in certain agreements with our counterparties. We have elected to not offset the fair values of derivative assets and liabilities executed with the same counterparty that are generally subject to enforceable netting agreements. Changes in a derivative’s fair value are recognized in earnings unless specific hedge criteria are met, and we elect hedge accounting prior to entering into the hedge. If a derivative is designated as a fair value hedge, the changes in fair value of both the derivative and the hedged item attributable to the hedged risks are recognized in the same line item in the results of operations. If the derivative is designated as a cash flow or net investment hedge, changes in the fair value related to the derivatives considered highly effective are initially recorded in accumulated other comprehensive income (loss) and subsequently classified to the consolidated statements of operations when the hedged item impacts earnings, and in the same line item on the consolidated statements of operations as the impact of the hedge transaction. Cash flows from all derivative instruments, including those not designated as hedging instruments, are classified in the same category as the cash flows from the item being hedged.
At the inception of a fair value, cash flow hedge or net investment hedge we formally document the hedge relationship and the risk management objective for undertaking the hedge. In addition, for derivatives that qualify for hedge accounting, we assess, both at inception of the hedge and on an ongoing basis, whether the derivative financial instrument is and will continue to be highly effective in offsetting cash flows or fair value of the hedged item and whether it is probable that the hedged forecasted transaction will occur. Changes in the fair value of derivatives that do not qualify for hedge accounting, or fail to meet the criteria, thereafter, are also recognized in the consolidated statements of operations. Refer to Note 24 -Fair Value of Financial Instruments for more information on the fair value of our derivative assets and liabilities.
Revenue Recognition – Revenue is recognized when obligations under the terms of a contract with our customer are satisfied. Generally, this occurs with the transfer of control of our products or services. The transfer of control to the customer occurs at a point in time, usually upon satisfaction of the shipping terms within the contract. Revenue is measured as the amount of consideration we expect to receive in exchange for transferring goods or providing services. The taxes we collect are concurrent with revenue-producing activities (e.g., sales tax, value-added tax, and other taxes) are excluded from revenue.
Shipping and handling costs are treated as fulfillment costs and are not considered a separate performance obligation. Shipping and handling costs charged to customers and the related expenses are reported in revenues and cost of sales for all customers. The expected costs associated with our base warranties and field service actions continue to be recognized as expense when the products are sold. Refer to Note 11 -Warranty Liability for more information. Since payment is due at or shortly after the point of sale, the contract asset is classified as a receivable.
We do not adjust the promised amount of consideration for the effects of a significant financing component when we expect, at contract inception, that the period between our transfer of a promised product or service to a customer and when the customer pays for that product or service will be one year or less. We do not typically include extended payment terms in our contracts with customers. Incidental items that are immaterial in the context of the contract are recognized as expense.
We disaggregate revenues based on geographical location. Refer to Note 14 -Segment Information for more information on disaggregated revenue.
Advertising Costs – All costs of advertising our products and services are charged to expense as incurred. For the years ended December 31, 2024, 2023 and 2022, advertising and promotion expenses were $27.9 million, $30.1 million and $27.1 million, respectively, and are included in SG&A expense in the accompanying consolidated statements of operations.
Net Interest Expense and Extinguishment of Debt Costs – We record debt extinguishment costs separately from interest expense, net within the consolidated statements of operations.
Foreign Currency Translation and Adjustments – Typically, our foreign subsidiaries maintain their accounting records in their local currency. All the assets and liabilities of these subsidiaries (including long-term assets, such as goodwill) are converted to U.S. dollars at the exchange rate in effect at the balance sheet date, income and expense accounts are translated at average rates for the period, and shareholder’s equity accounts are translated at historical rates. The effects of translating financial statements of foreign operations into our reporting currency are recognized as a cumulative translation adjustment in consolidated other comprehensive income (loss). This balance is net of tax, where applicable.
The effects of translating financial statements of foreign operations in which the U.S. dollar is their functional currency are included in the consolidated statements of operations. The effects of translating intercompany debt are recorded in the consolidated statements of operations unless the debt is of a long-term investment nature in which case gains and losses are recorded in consolidated other comprehensive income (loss).
Foreign currency transaction gains or losses are credited or charged to income as incurred.
Income Taxes – Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on the deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. We evaluate both the positive and negative evidence that is relevant in assessing whether we will realize the deferred tax assets. A valuation allowance is recorded when it is more likely than not that some of the deferred tax assets will not be realized. The tax effects from an uncertain tax position can be recognized in the consolidated financial statements, only if the position is more likely than not to be sustained, based on the technical merits of the position and the jurisdiction taxes of the Company. We recognize the financial statement benefit of a tax position only after determining that the relevant tax authority would more likely than not sustain the position following an audit and the tax related to the position would be due to the entity and not the owners. For tax positions meeting the more likely than not threshold, the amount recognized in the consolidated financial statements is the largest benefit that has a greater than 50 percent likelihood of being realized, upon ultimate settlement with the relevant tax authority. We apply this accounting standard to all tax positions for which the statute of limitations remains open. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs.
We file a consolidated federal income tax return in the U.S. and various states. For financial statement purposes, we calculate the provision for federal income taxes using the separate return method. Certain subsidiaries file separate tax returns in certain countries and states. Any U.S. federal, state, and foreign income taxes refundable and payable are reported in other current assets and accrued expenses and other current liabilities in our consolidated balance sheet. We have non-current taxes receivable or payable at December 31, 2024 - see Note 15 -Income Taxes for more information. We do not have any non-current taxes receivable or payable at December 31, 2023.
We record interest and penalties on amounts due to tax authorities as a component of income tax expense in the consolidated statements of operations. We have elected to account for the impact of GILTI in the period in which it is incurred.
Contingent Liabilities – Contingent liabilities arising from claims, assessments, litigation, fines, penalties, and other sources require significant judgment in determining the probability of loss and the amount of the potential loss. Each quarter, we review significant new claims and litigation for the probability of an adverse outcome. Estimates are recorded as liabilities when it is probable that a liability has been incurred, and the amount of the loss is reasonably estimable. Disclosure is required when there is a reasonable possibility that the ultimate loss will materially exceed the recorded provision. Contingent liabilities are often resolved over long time periods. Estimating probable losses requires analysis of multiple forecasts that often depend on judgments about potential actions by third parties, such as regulators, and the estimated loss can change materially as individual claims develop. Legal costs incurred in connection with loss contingencies are expensed as incurred.
Employee Retirement and Pension Benefits – We have a defined benefit plan available to certain U.S. hourly employees and several other defined benefit plans located outside of the U.S. that are country specific. The most significant of these plans is in the U.S., which is no longer open to new employees. Amounts relating to these plans are recorded based on actuarial calculations, which use various assumptions, such as discount rates and expected return on assets. Refer to Note 26 -Employee Retirement and Pension Benefits for more information.
Recently Adopted Accounting Standards – In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting, which provides optional expedients and exceptions for applying U.S. GAAP to contracts, hedging relationships, and other transactions affected by the discontinuation of LIBOR or by another reference rate expected to be discontinued. In January 2021, the FASB issued ASU No. 2021-01, Reference Rate Reform (Topic 848): Scope, to clarify the scope of ASU No. 2020-04. In December 2022, the FASB issued ASU No. 2022-06, Deferral of the Sunset Date of Topic 848, which extended the relief provisions under Topic 848 through December 31, 2024. In May 2020, we elected the expedient within ASC 848 which allowed us to assume that our hedged interest payments were probable to occur regardless of any expected modifications in their terms related to reference rate reform. In addition, ASC 848 allowed for the option to change the method of assessing effectiveness upon a change in critical terms of the derivative or the hedged transactions and upon the end of relief under ASC 848. We elected to assess effectiveness as documented in the original hedge documentation and apply the practical expedients related to probability to assume that the reference rate on a hypothetical derivative matched the reference rate on the hedging instrument. In June 2023, we executed amendments to our Term Loan Facility, ABL Facility and interest rate derivative agreements to replace LIBOR with a Term SOFR based rate. These contract amendments did not have a material impact on our consolidated financial statements. Refer to Note 12 -Long-Term Debt and Note 23 -Derivative Financial Instrumentsfor more information.
In November 2023, the FASB issued ASU 2023-07, Improvements to Reportable Segment Disclosures. ASU 2023-07 requires disclosure of significant segment expenses that are regularly provided to the CODM and included within the segment measure of profit or loss, an amount and description of the composition for other segment items to reconcile to segment profit or loss, and the title and position of the entity’s CODM. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. We adopted this guidance effective January 1, 2024, for annual reporting and applied the amendments retrospectively to all prior periods presented in the Consolidated Financial Statements. The amendments for interim periods will be adopted in our fiscal year beginning on January 1, 2025. Refer to Note 14 -Segment Informationfor more information.
Recent Accounting Standards Not Yet Adopted – In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. ASU 2023-09 expands disclosures in an entity’s income tax rate reconciliation table and regarding cash taxes paid both in the U.S. and foreign jurisdictions. The guidance is effective for annual periods beginning after December 15, 2024, with early adoption permitted, and should be applied either prospectively to financial statements issued for reporting dates after the effective date or retrospectively to any or all prior periods presented in the financial statements. We have not elected to early adopt this standard. We are currently evaluating the impact of this guidance on the Company’s disclosures.
In November 2024, the FASB issued ASU 2024-03, Expense Disaggregation Disclosures: Disaggregation of Income Statement Expenses. ASU 2024-03 requires disclosure of certain costs and expenses on a fiscal and interim basis in the notes to the financial statements. ASU 2024-03 is effective for annual reporting periods in fiscal years beginning after December 15, 2026, and interim reporting periods within fiscal years beginning after December 15, 2027, with early adoption permitted, and should be applied either prospectively to financial statements issued for reporting dates after the effective date or retrospectively to any or all prior periods presented in the financial statements. We are currently evaluating the impact of this guidance on the Company’s disclosures.
We have considered the applicability and impact of all ASUs. We have assessed ASUs not listed above and determined that they were either not applicable or were not expected to have a material impact on our financial statements.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.